RAPT
RAPT TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
RAPT Profile
Rapt Therapeutics, Inc.
A clinical-stage biopharmaceutical company focused on developing oral small molecule therapies for cancer and inflammatory diseases
561 Eccles Avenue, South San Francisco, California 94080
--
RAPT Therapeutics, Inc., was incorporated in March 2015 under the laws of the State of Delaware. The Company is a clinical-stage, immunology-based biopharmaceutical company dedicated to the discovery, development and commercialization of oral small molecule therapies for patients who are not fully satisfied in oncology and inflammatory diseases. Using its proprietary drug discovery and development engine, the company develops highly selective small molecules designed to modulate key immune responses in these diseases.
